Phillip A Dennis

Repositioning HIV protease inhibitors as cancer therapeutics

P. Dennis, Wendy B Bernstein, Phillip A Dennis, 2008, Current opinion in HIV and AIDS.

Inhibition of the phosphatidylinositol 3-kinase/Akt/mammalian target of rapamycin pathway but not the MEK/ERK pathway attenuates laminin-mediated small cell lung cancer cellular survival and resistance to imatinib mesylate or chemotherapy.

J. Gills, P. Dennis, K. West, 2005, Cancer research.

Guidelines for the use and interpretation of assays for monitoring autophagy in higher eukaryotes

John L Cleveland, Masaaki Komatsu, Katsuhiko Kitamoto, 2008, Autophagy.

Akt-dependent and -independent mechanisms of mTOR regulation in cancer.

R. Memmott, P. Dennis, Phillip A Dennis, 2009, Cellular signalling.

Activation of the PI3K/Akt pathway and chemotherapeutic resistance.

P. Dennis, K. West, Phillip A Dennis, 2002, Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy.

Targeting the PI3K/Akt/mTOR pathway: effective combinations and clinical considerations.

J. LoPiccolo, P. Dennis, G. Blumenthal, 2008, Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy.

Novel PI analogues selectively block activation of the pro-survival serine/threonine kinase Akt.

P. Dennis, J. Brognard, A. Kozikowski, 2003, Journal of the American Chemical Society.